| Source HCPCS Code |
|
Target NDC Code |
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0024-00
CASIRIVIMAB(REGN10933) 1,33
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
11.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0024-01
CASIRIVIMAB(REGN10933) 1,33
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
11.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0025-00
IMDEVIMAB (REGN10987) 1,332
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
11.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0025-01
IMDEVIMAB (REGN10987) 1,332
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
11.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0026-00
CASIRIVIMAB (REGN10933) 300
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0026-01
CASIRIVIMAB (REGN10933) 300
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0027-00
IMDEVIMAB (REGN10987) 300 M
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0027-01
IMDEVIMAB (REGN10987) 300 M
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
2.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0240
Inj, casirivimab and imdevimab, 600 mg
|
⇄
|
61755-0039-01
REGEN-COV 600-600 MG/10ML(E
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|